Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Recommendation of “Buy” from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has received an average rating of “Buy” from the eleven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $134.22.

A number of research analysts have weighed in on the company. JMP Securities began coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target for the company. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th.

Addus HomeCare Stock Down 0.9 %

Shares of ADUS opened at $125.16 on Friday. The company has a 50 day moving average of $126.86 and a 200-day moving average of $127.31. The stock has a market capitalization of $2.27 billion, a P/E ratio of 28.64, a P/E/G ratio of 1.63 and a beta of 1.00. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 EPS. On average, sell-side analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

Several large investors have recently modified their holdings of ADUS. Janney Montgomery Scott LLC lifted its position in Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock worth $1,340,000 after purchasing an additional 91 shares during the period. Inspire Investing LLC boosted its position in shares of Addus HomeCare by 3.3% during the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after acquiring an additional 100 shares in the last quarter. New York State Teachers Retirement System boosted its position in shares of Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after acquiring an additional 100 shares in the last quarter. Equitable Trust Co. raised its position in Addus HomeCare by 2.2% during the third quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after purchasing an additional 106 shares in the last quarter. Finally, Royce & Associates LP lifted its stake in Addus HomeCare by 1.2% during the third quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock worth $1,187,000 after purchasing an additional 109 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.